EARLIER WORK from this and other laboratories has established that embryoimmunized lymphocyte populations can confer protection (growth retardation) against s.c. implants of tumour cells in syngeneic hosts, and can decrease lung metastases in a rat hepatoma system (Gorczynski & MacRae, unpublished and 1981; Baldwin et al., 1974) . There is evidence in the literature that the state of macrophage activation, and the infiltration of such cells into the tumour mass, is correlated with metastases in the autologous host (Hibbs, 1973; Eccles & Alexander, 1974 ). In contrast, our studies have suggested that lymphoid cells, the activity of which can also be assessed in a 48h in vitro microcytotoxicity test, are the predominant effector-cell populations in regulating local (s.c.) growth of tumour cells (Gorezynski & MacRae, unpublished) . An alternative cytotasis assay, also performed over a 48h culture period, detects, in addition to cytotoxic lymphocytes, other effector-cell populations (adherent, non-0-bearing) which also appear after * To w}liom all corres;pon(lence silioul( be a(ldressed. deliberate exposure (during pregnancy or growth of tumours bearing neoantigens) of spleen cells to embryo-associated antigens in vitro or in vivo (Gorczynski & MacRae, 1981) .
We have analysed the kinetics of appearance and loss of cytostatic effectorcell activity in the spleen of tumourbearing and tumour-resected mice, and the heterogeneity of sensitivity of tumourcell subpopulations (within one solid tumour mass) to cytostasis by a given activated cell population (Gorczynski & MacRae, 1981) . These data suggested that our cytostasis assay may enable us to determine:
(i) the events in the lymphoid hierarchy of the host which may encourage the development of secondary tumour growth, and
(ii) the cells within a given tumour which have a potential for metastasis.
Both of these questions have been approached in the experiments described below, by correlation of a series of analyses on 4 independent assays per-formed with either a standard tumour-cell population and a variety of effector cells, or the converse. Three of these assays, in vitro cytotoxicity and cytostasis assays, and in vivo growth modulation of s.c. implants of tumour cells, have been described in detail elsewhere (Gorczynski, 1978; Gorezynski & MacRae, unpub. and 1981) . The 4th assay, lung colony growth after i.v. inoculation of tumour cells into irradiated mice, is documented below. The data support the notion that the events associated with the regulation of cellular cytostasis for embryo-antigen-bearing target (Gorezynski, 1978; Russell et al., 1976) . 14 x 107 cells were frozen at -70°C in x-MEM containing dimethyl sulphoxide (DMSO) (15%) and foetal calf serum (30%) in aliquots of 3x 106 cells (concentration 1-5 x 106/ml). All experiments reported below used as starting material the cells prepared from an s.c. tumour produced in normal (8-week) female mice upon transplantation of 2 x 106 cells recovered from this frozen stock (mean recovery of viable cells on thawing was 40 + 10%)-the tumour grew to a mean volume of 1-8 cm3 (±0 3 cm3) after 20 days of transplantation of "thawed" primary cells.
Tumour resection was performed under ether anaesthesia as described in individual experiments. Tumour volume was measured with calipers, the volume being assessed by the formula: volume=0 4ab2 where a is the maximum dimension of the tumour and b is the diameter at right angles to a (Attia et al., 1965) .
Preparation of embryofibroblasts, spleen cells and techniques of velocity sedimentation and cell culture. These procedures were performed as described elsewhere (Gorezynski, 1978) .
Microcytotoxicity and cytostasis assays (Gorczynski, 1978; Gorczynski & MacRae, 1981) .-In brief, 2 x 103 embryo fibroblast target cells (either pre-labelled with 3H-proline for cytotoxicity assay, or postlabelled at 48 h with [3H]-dT for cytostasis assay) were dispersed in 100 ,ul into wells of a 96-well Linbro microtitre plate. After allowing 3 h for the target cells to adhere, effector cells were added in a final volume of 200 ,ul at different concentrations to the well. All groups of varying effector:target ratios were set up in triplicate. Control groups contained only medium added to the targets (spontaneous cytotoxicity/cytostasis) or water (total releasable ct/min-cytotoxicity: maximum growth inhibition-cytostasis). At 48 h plates in the cytotoxicity assay were centrifuged at 500 g for 5 min at 4°C; 100 ,ld of the supernatant in each well was dissolved in 5 ml Aquasol (New England Nuclear, Boston, Mass.) ct/min experimental ct/mmn spontaneous -ct/min H20 As described elsewhere, this is an accurate reflection of cytostatic activity only in the absence of cytotoxicity from the population under test (Gorczynski & MacRae, 1981) .
In (Freund, 1962 (Gorczynski, 1978; Gorczynski & MacRae, 1981 and cytotoxicity assays were not identical cell populations. In the absence of a highly metastatic spontaneous adenocarcinoma, we have resorted to another means of studying the regulation of growth of tumour cells which escape into the systemic circulation, by deliberately transferring different i.v. doses of tumour cells (3x 10 or 3 x 105) in 0 5 ml PBS to groups of 5 sublethally irradiated (6 Gy) recipients Fig. 1(a) . An inert "carrier" cell population (20 Gy syngeneic normal spleen cells, 2 x 107 per recipient) was included in some recipients (@-*, compare with x -x, no carrier cells) to study whether "seeding" of tumour cells to the lung was more effective at the various tumour-cell dilutions in the presence of such a carrier (Hill & Stanley, 1975) . The data of this panel (a) of Fig Correlation between in vitro and in vivo assays for detecting effector cells regulating the growth of cells with embryo-associated antigenic determinants We have described both in vitro (cytotoxicity and cytostasis) and in vivo (regulation of growth of s.c. tumour implants; inhibition of lung colony growth after i.v. inoculation) assays which detect effector cells expressing activity against spontaneously appearing adenocarcinoma target cells. Spleen lymphoid cells precultured for 5 days are known to express activity in the first 3 assays mentioned, though the in vitro cytotoxicity assay was found to be better correlated with regulation of growth of s.c. tumour implants than the cytostasis assay (Gorczynski & MacRae, uinpublished) . In order to assess the ability of cultured spleen cells to affect tumourcell growth as lung colonies, we cultured 5 x 108 female spleen lymphoid cells in In addition to these in vitro assays, 8% of the cells of each fraction (an unfractionated equivalent of 2-5 x 106 cells) was injected i.v. into 2 groups of 5 per group C3H/HeJ female mice, either given 6 Gy or 9-5 Gy and 5 x 106 syngeneic marrow cells 2 h earlier. The group of 5 mice receiving 6 Gy were given 3 x 105 tumour cells i.v. 6 h after spleen-cell transfer, the other group receiving 106 tumour cells s.c. 7 days later. All tumour cells used were from a spontaneously appearing adenocarcinoma (adeno29). Lung colonies were examined in the former groups at 21 days, and tumour growth in the latter groups measured with calipers every 3 days after the appearance of palpable tumour. The data for one experiment (of 3) of this type are shown in Fig. 2 (tumour volumes for these groups were assessed at Day 38).
Visual inspection of these data, coupled with statistical analysis of the coefficient of correlation for the activity profiles represented by individual panels (see Table I ) provides evidence that whilst activity in an in vitro cytotoxicity test is better correlated with inhibition of local s.c. growth of tumours than appearance of lung nodules after i.v. injection of tumour cells (r=0.90 vs r=0.57) assays for cytostatic activity appear to detect preferentially those cells capable of regulating an i.v. challenge of tumour cells (r=0.99) rather than those regulating an (Gorezynski & MacRae, 1981) . The kinetics of development of overall effectorcell activity in spleen cells of pregnant animals was consistent with the idea of the early production of both a fastsedimenting and a slow-sedimenting cytostatic effector-cell progenitor (e.g. as in Fig. 2 ) with late activity residing mainly in a slow-sedimenting (memory?) cell population. In mice inoculated with tumour cells the early activity did indeed appear in two physically distinct cell populations, but mice analysed later after tumour resection, provided little evidence for cytostatic effector-cell each group were killed for use as spleencell donors. Five x 108 spleen cells of each pool were sedimented for 3 h at 4°C, and the populations of cells sedimenting in the regions 2*5-4'5 or 6-9 mni/h collected as previously determined. Each population of cells was resuspended to a concentration of 107 cells/ml and assayedin triplicate at various dilutions (105, 3 x 104, 104 and 3 x 103 cells/well) for cytostasis to 103 14-day-old C3H embryo fibroblast target cells (Fig.  3a) . In addition, 9 x 106 cells of each population were inoculated i.v. into groups of 5 normal age-matched females, pretreated 2 h before with 6 Gy and subsequently given 3 x 105 adeno29 cells i.v.; a control group of mice received only irradiation and tumour cells (0 in Fig. 3b) . Finally, the remaining 5 mice of each of the initial tumour inoculated mice were given 6 Gy followed within 2 h by 3 x 105 adeno29 cells i.v. (Fig. 3c) . All mice were killed and examined macroscopically for tumour lung colonies on Day 23 after i.v. transplantation of tumour cells.
The data of Fig. 3 are representative of the results obtained for this study, which has been repeated in toto on two separate occasions. It is clear from these data (lefthand panel a, b) that fast-sedimenting cells from tumour-bearing mice, or from mice 20 and 40 days after tumour resection, have appreciable cytostatic activity in vitro and a pronounced capacity to inhibit lung colony growth of i.v. injected tumour cells. However, at 80 days after tumour resection, both in vitro cytostasis and in vivo activity are markedly diminished. These effects are even more pronounced when slow-sedimenting effector cells are investigated (Fig. 3a,b right-hand panel), though now interestingly even tumour-bearer spleen cells were relatively inactive in each assay. Most dramatically, when the donors of the spleen cells used in in vitro cytotoxic or in vivo lung colony assays (a, b) were themselves used as recipients of i.v. tumour cells (c) the numbers of lung colonies detected in these groups of mice were highly correlated with the activity of small and large splenic effector cells in the assays of cytostasis and growth of lung colonies. (Large cells for cytostatic and lung colony assays r = 0 85 + 0-17) 0'84 + 0 25 respectively; small cells for cytostatic and lung colony assays, r= 0*79 + 014, 0485 + 016 respectively.) Note here and throughout the paper that these correlation coefficients are derived from statistical treatment of data from individual animals, whilst the data shown in the Figure " pre-group" these data, and show only the arithmetic means of the discrete groups.
Differential susceptibility of populations of cells from a solid tumour m8ss to cytostasis by effector cells in vitro and lung-colony growth regulation in vivo Earlier studies suggested that cells isolated by enzymatic digestion from within a growing solid tumour, and subsequently separated into discrete subpopulations by velocity sedimentation, were highly heterogeneous in their susceptibility to the cytostatic activity of different cell populations (Gorczynski & MacRae, 1980b) . If these differences reported earlier are truly reflective of heterogeneity in tumour cells of a given solid tumour, separation of tumour cells by velocity sedimentation should reveal this heterogeneity of the tumour cells.
A group of 4 mice were inoculated s.c.
with 2 x 106 adeno29 cells in 0 I ml PBS.
When the tumour mass was -1-5 cm3 in all recipients (range 2 3-1 0 cm3) all mice were killed, the tumours pooled, and an enzymatic digest of the tumour was prepared. Five x 107 cells were separated for 2 h at 4°C, and the fractions shown in Fig. 4 (Gorczynski & MacRae, 1981) The data shown in Fig. 3 presented a case for a possible role of cytostatic effector cells present in tumour-bearer mice and in mice shortly after tumour resection (e.g. 20 days) in controlling lung colony formation as assessed by autologous, adoptively transferred tumour cells in secondary hosts. The data presented above (Fig. 4) in turn have suggested that within a solid tumour mass there are tumorigenic cells which are unresponsive in vitro to cytostatic effector cells. These cells are notably capable of resisting the inhibitory effect upon lung colony formation in an adoptive-transfer assay of a deliberately induced cytostatic effector population. These experiments collectively suggest that subpopulations of cells within a given solid tumour will show different patterns of susceptibility to cytostasis in vitro and lung colony growth (after i.v. Fig. 5 ). Analysis ofthe curves shown as (O -0), (0-0) in the right-and left-hand panels of this figure re-emphasizes the point made initially in Fig. 3 , namely that whilst fast-sedimenting effector cells of both tumour-bearer and 40-day-resected spleen donors can produce cytostasis and lung colony growth inhibition, the slow-sedimenting effector cells in tumour-bearer animals are singularly incapable of either. However, inspection of the data in terms of heterogeneity of tumour cells is equally revealing. It is apparent that the different activity of spleen cells from tumourbearers and tumour-resected individuals is most pronounced with slow-sedimenting (< 15 (Gorczynski & MacRae, 1980a) .
However, when tumour cells were allowed to seed to the lung of recipient mice (after i.v. transfer), the cytotoxic potential of a given effector-cell pool was found to give a poor reflection of its capacity to modulate tumour lung colonies (Fig. 2) . In contrast, an assay measuring the cytostatic capacity of the effector-cell preparation was able to predict the in vivo efficiency of the effector cells in regulating lung-colony function in vivo (Fig. 2) . This is consistent with our own and other workers' earlier observations that: (i) cytotoxic effector cells are predominantly lymphocytic in origin (Gorczinski, 1976) in contrast to those cells which exert cytostasis in vitro (lymphocyte and non-lymphocyte cell pools) (Gorczynski & MacRae, 1981; Owen & Seeger, 1973) , and (ii) the degree of non-lymphocyte (macrophage) infiltration of solid tumours reflects the metastatic potential of the tumour, and tumour metastasis itself may be experimentally controlled by transfer of activated macrophages (see also Fig. 1) (Hibbs, 1973; Eccles & Alexander, 1974; Fidler, 1974) . Indeed, recent data by Fidler (1980) (Gorczynski & MacRae, 1981) . We suggested that this in turn might be reflected in a diminished ability of lymphoid cells from such animals to control distal spread of tumour cells, a possibility which was further explored in the experiment described in Fig. 3 . Using an alternative system to examine regulation of systemic tumour growth, we did find that long after tumour resection (80 days) spleen lymphocytes from these donors were unable to produce a decrease in growth of adoptively transferred tumour cells, and in fact these recipients (used as hosts for the tumour) supported a greater lung-colony growth than normal animals (see Fig. 3 ). It should be noted as a point of reservation to this last analysis, that while control groups (tumour resected, irradiated, no i.v. tumour cells) did not contain lung colonies on the day of assay, one interpretation of the data that is not yet conclusively overruled is that additional i.v. tumour cells enhanced the subsequent growth of latent colonies in these recipients.
There is abundant experimental evidence for the notion that tumours are heterogenous for a variety of phenotypic characteristics, of which metastatic potential is but one (Poste & Fidler, 1980) . In line with these studies, we have shown that the heterogeneity (in terms of in vitro susceptibility to cytostasis by a given pool of effector cells) of subpopulations of cells isolated from a given solid tumour mass is apparent in the inhibition of lung colony growth by effector cells. A strong correlation existed between those cells susceptible to cytostasis in vitro and to growth inhibition of lung colonies in vivo (Fig. 4) . In an experiment which synthesized the findings of Figs 3 and 4, we showed that this heterogeneity (differential susceptibility to growth regulation in vitro and in vivo) of tumour cells can be demonstrated using as an effector-cell source cytostatic effector cells from tumour-stimulated animals (Fig. 5) . These findings suggest that an explanation for tumour metastasis is two-fold:
(1) a decline in cytostatic (regulator) effector cells within the tumour bearer, and (2) the appearance of tumour cells refractory to their activity.
If these tumour cells are genuinely refractory to cytostatic effector cells, the phenomenon we have described may perhaps be distinct from that of Kerbel (1979) , who reported the unsuccessful attempt to select for tumour cells resistant to macrophage cytotoxicity in vitro, despite successful selection of cells resistant to other toxic regimes. However, with the growing body of data suggesting a role for a non-macrophage, natural killer (NK) cell which is capable of causing spontaneous cell-mediated cytotoxicity to tumour cells in species including man and mice (Herberman & Holden, 1978) and is implicated in immune surveillance and tumour immunity (Haller et al., 1977) it is perhaps unwise to speculate, in the absence of concrete evidence, on the actual nature of the effector cell investigated here.
Indeed, the decline in activity may be more apparent than real (e.g. see in vitro and in vivo activity measured from slowsedimenting spleen cells of tumourresected animals with tumour cells sedimenting at 7-12 mm/h in Fig. 5 ). The diminished activity we measured may reflect the ability of fast-sedimenting tumour cells to induce cells (suppressors) which counteract the activity of cytostatic effector cells (e.g. 0-0 for tumour cells sedimenting in the region [15] [16] [17] [18] [19] [20] mm/h in the lower right panel of Fig. 5 indicates greater lung nodule formation than in control mice ( x -x ) given tumour cells alone). A role for suppressor cells capable of neutralizing the activity of cytotoxic effector cells in the regulation of local s.c. growth of tumour cells has been described by us (Gorezynski & MacRae, unpublished) . Future studies will require an assessment of the correlation between these findings and the general phenomenon of promotion of lung-colony formation reported here.
